MedImmune says new FluMist better than a shot
12th Dec 2005, 18:06 GMT
MedImmune stock rallied Monday after the company said clinical trials with young children showed its new version of FluMist is more effective than a shot in protecting them against the flu.
MedImmune says new FluMist better than a shot related news:
- MedImmune Says New FluMist Better Than a Shot and ViroPharma Incorporated Announces Completion of Offering — Financial News USA (OTC: FNWU)
- Successful FluMist Tests Could Revive MedImmune — washingtonpost.com - Metro Business
- New FluMist shows promise in trial — baltimoresun.com - business
- MedImmune's FluMist is seen in an undated file photo. MedImmune ... — Top Stories Photos - Reuters on Yahoo! News Photos
- MedImmune receives FluMist study boost — Pharmaceutical Business Review Online
- Tests Could Revive MedImmune's FluMist — washingtonpost.com - Business
- FluMist Succeeds in Key Trial, Maker Says — washingtonpost.com - Health
- FluMist Excels In Key Trial, Maker Says — washingtonpost.com - Business
- Spray flu vaccine performs well in trial — United Press International - NewsTrack
- Refrigerator-Stable FluMist Reduces Flu Risk: Study — KLTV - Med Team
Latest news from Latest news from Baltimore Business Journal:
- Venture capital firm raises $260 million for investments
- African-American TV channel adds million more homes
- Baltimore Tech Park names new president
- Hopkins to receive $20M for cancer research
- Downtown Partnership to use parking meters for city homeless donations
- Survey: Companies 'in a party mood' for holidays
- 'No runaway growth here,' Arundel planning officials say
- Employees to boss: Pay is a priority
- BofA, Aetna launch credit card